W Siegenthaler

8.1k total citations · 1 hit paper
305 papers, 5.4k citations indexed

About

W Siegenthaler is a scholar working on Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, W Siegenthaler has authored 305 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Endocrinology, Diabetes and Metabolism, 69 papers in Pulmonary and Respiratory Medicine and 53 papers in Surgery. Recurrent topics in W Siegenthaler's work include Hormonal Regulation and Hypertension (70 papers), Renal and Vascular Pathologies (28 papers) and Electrolyte and hormonal disorders (26 papers). W Siegenthaler is often cited by papers focused on Hormonal Regulation and Hypertension (70 papers), Renal and Vascular Pathologies (28 papers) and Electrolyte and hormonal disorders (26 papers). W Siegenthaler collaborates with scholars based in Switzerland, Germany and United States. W Siegenthaler's co-authors include A Grüntzig, A Senning, W. Vetter, H. Vetter, R Lüthy, U. Kuhlmann, M Schlumpf, C Werning, Andreas R. Gruentzig and Spencer B. King and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

W Siegenthaler

276 papers receiving 4.8k citations

Hit Papers

Nonoperative Dilatation o... 1979 2026 1994 2010 1979 500 1000 1.5k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
W Siegenthaler 2.5k 1.8k 1.5k 1.0k 664 305 5.4k
Craig R. Smith 3.2k 1.3× 1.7k 1.0× 1.3k 0.9× 461 0.4× 200 0.3× 113 6.0k
Ludovic Drouet 2.0k 0.8× 2.8k 1.6× 1.4k 0.9× 407 0.4× 423 0.6× 227 7.3k
Daniel Duprez 1.9k 0.8× 5.2k 2.9× 1.1k 0.8× 610 0.6× 1.3k 2.0× 285 9.8k
Joel Morganroth 1.4k 0.6× 7.2k 4.0× 793 0.5× 1.1k 1.1× 314 0.5× 269 9.7k
Harvey J. Berger 1.4k 0.5× 3.7k 2.1× 1.3k 0.9× 2.2k 2.1× 129 0.2× 108 6.4k
J.R.A. Mitchell 643 0.3× 1.7k 1.0× 698 0.5× 312 0.3× 363 0.5× 126 4.8k
Christian Müller 1.4k 0.6× 2.0k 1.1× 2.0k 1.3× 560 0.5× 414 0.6× 207 6.9k
Per Hildebrandt 1.2k 0.5× 5.5k 3.1× 1.0k 0.7× 652 0.6× 2.0k 3.0× 170 8.5k
Evan Loh 1.8k 0.7× 7.9k 4.4× 1.4k 1.0× 502 0.5× 190 0.3× 90 11.3k
Andreas Mügge 2.2k 0.9× 6.4k 3.5× 2.0k 1.3× 1.0k 1.0× 644 1.0× 342 10.3k

Countries citing papers authored by W Siegenthaler

Since Specialization
Citations

This map shows the geographic impact of W Siegenthaler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W Siegenthaler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W Siegenthaler more than expected).

Fields of papers citing papers by W Siegenthaler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W Siegenthaler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W Siegenthaler. The network helps show where W Siegenthaler may publish in the future.

Co-authorship network of co-authors of W Siegenthaler

This figure shows the co-authorship network connecting the top 25 collaborators of W Siegenthaler. A scholar is included among the top collaborators of W Siegenthaler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W Siegenthaler. W Siegenthaler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schwitter, Juerg, et al.. (2008). Hirnabszeß als Komplikation des Morbus Osler mit Lungenbeteiligung. DMW - Deutsche Medizinische Wochenschrift. 116(42). 1591–1596.
2.
Flepp, Markus, et al.. (1986). [Transfusion-associated LAV/HTLV-III infections in Switzerland. Report of 2 cases].. PubMed. 116(14). 426–8. 2 indexed citations
3.
Lüscher, Thomas F., P Greminger, U. Kuhlmann, et al.. (1986). Renal Venous Renin Determinations in Renovascular Hypertension. ˜The œNephron journals/Nephron journals. 44(1). 17–24. 20 indexed citations
4.
Wanner, C., et al.. (1985). Curable Renal Parenchymatous Hypertension: Current Diagnosis and Management. Cardiology. 72(1). 33–45. 4 indexed citations
5.
Oelz, O, et al.. (1984). [Acquired immune deficiency syndrome in the region of Zurich. Report on 12 cases].. PubMed. 114(39). 1314–26. 3 indexed citations
6.
Lüscher, T, et al.. (1984). Transluminal Dilatation of Experimental Hydronephrosis in Dogs: Acute and Chronic Effects, Haemodynamic Changes, and Histological Findings. Urologia Internationalis. 39(4). 225–231. 1 indexed citations
7.
Kuhlmann, Uwe, et al.. (1981). Platelet aggregation and beta-thromboglobulin levels in nephrotic patients with and without thrombosis.. PubMed. 15(5). 229–35. 29 indexed citations
8.
Lüthy, R, et al.. (1979). [On-line measurement of antibiotic concentrations (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 179–84. 1 indexed citations
9.
Siegenthaler, W & R Lüthy. (1978). Current chemotherapy : proceedings of the 10th International Congress of Chemotherapy, Zurich/Switzerland, 18-23 September 1977. 1 indexed citations
10.
Greminger, P, W. Vetter, Katharina Zimmermann, R. Beckerhoff, & W Siegenthaler. (1977). [Primary and secondary hypertension in polyclinical patients].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 107(17). 605–9. 12 indexed citations
11.
Vetter, W, K Záruba, R. Beckerhoff, et al.. (1976). Control of plasma aldosterone in terminal renal failure before and after nephrectomy and after renal transplantation.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 6(4). 433–6. 2 indexed citations
12.
Beckerhoff, R., J Furrer, W. Vetter, Juerg Nussberger, & W Siegenthaler. (1976). Hypotension during angiotensin blockade with saralasin.. BMJ. 2(6040). 849–849. 3 indexed citations
13.
Siegenthaler, Georges, et al.. (1975). [Recent advances in hypertension therapy (author's transl)].. PubMed. 64(13). 373–82. 1 indexed citations
14.
Vetter, W., et al.. (1975). Severe arterial hypertension caused by chronical abuse of a topical mineralocorticoid.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 12(1-2). 170–3. 5 indexed citations
15.
Siegenthaler, W, et al.. (1975). [Pulmonary involvement in collagen diseases].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 70(45). 1801–14. 2 indexed citations
16.
Vetter, H., W. Vetter, & W Siegenthaler. (1974). Preparation of an antiserum specific to aldosterone and its application in radioimmunoassay. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 88(2). 257–66. 1 indexed citations
17.
Werning, C, et al.. (1970). [Importance of renin-angiotensin-aldosterone system in diverse forms of hypertension].. PubMed. 59(20). 730–7. 4 indexed citations
18.
Weidmann, P, et al.. (1968). Plasma Renin Activity and Angiotensin Pressor Dose in Hypertension: Correlation and Diagnostic Implications. BMJ. 3(5611). 154–156. 32 indexed citations
19.
Siegenthaler, W. (1967). [The present situation of treatment of hypertension].. PubMed. 56(5). 154–62. 1 indexed citations
20.
Marti, Hanna, et al.. (1965). Hämoglobin C bei Europäern: Ein neuer, wahrscheinlich homozygoter und 3 heterozygote Träger der Anomalie. Annals of Hematology. 11(6). 321–325. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026